International Association for the Study of Lung Cancer

The PD-L1 inhibitor durvalumab showed an overall survival benefit in patients with unresectable stage III non–small cell lung cancer (NSCLC) in the phase 3 PACIFIC trial.

Researchers are chipping away at the genetic subtypes of non–small-cell lung cancer (NSCLC).
Entrectinib achieved high response rates as well as durable responses in patients with ROS1-positive non–small cell lung cancer (NSCLC), including patients with brain metastases, according to a pooled analysis of phase 1 and 2 trials.
Atezolizumab combined with carboplatin/etoposide represents a new standard of care for first-line treatment of extensive-stage small cell lung cancer (ES-SCLC), according to results from the phase 3 IMpower133 trial presented at the IASLC 19th World Conference on Lung Cancer.
Brigatinib significantly prolonged survival compared with crizotinib (standard of care) as first-line therapy in patients with advanced anaplastic lymphoma kinase (ALK)-positive non–small cell lung cancer (NSCLC).
Progress has been made in lung cancer treatment, but as patients are living longer, addressing the toxicities of their systemic therapy is becoming increasingly paramount. In this field of patient management, oncology nurses play a vital role, according to Tanja Cufer, MD, PhD, a medical oncologist and Professor of Oncology at Medical Faculty, University of Ljubljana, Slovenia, and Senior Counselor at the University Clinic in Golnik, Slovenia.
Remote monitoring can improve quality of care and patient outcomes in the management of people with cancer, according to Roma Maguire, PhD, MSc, BN, RGN.
Preoperative thoracic surgery education increases patient satisfaction and decreases patient anxiety and readmission rates associated with postoperative complications, all while optimizing overall outcomes for thoracic surgery patients, according to Katherine O. Kuhns, CRNP, a nurse practitioner specialist in thoracic surgery at the University of Pennsylvania Penn Presbyterian Medical Center.
In the delivery of survivorship programs, oncology nurses have a duty to the person as whole, not just to their cancer.
Page 1 of 2
Results 1 - 10 of 11

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code